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Abstract
Sustained intracranial hypertension and acute brain herniation are “brain codes,” signifying 
catastrophic neurological events that require immediate recognition and treatment to prevent 
irreversible injury and death. As in cardiac arrest, a brain code mandates the organized 
implementation of a stepwise management algorithm. The goal of this emergency neurological life 
support protocol is to implement an evidence-based, standardized approach to the evaluation and 
management of patients with intracranial hypertension and/or herniation.
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Introduction
The ENLS-suggested algorithm for the initial management of intracranial hypertension or 
herniation is shown in Fig. 1.
The sum of intracranial contents—brain, blood, and cerebrospinal fluid (CSF)—represents a 
fixed volume determined by the invariant constraints of the cranial vault [1, 2]. Relative 
volumes of these contents will change to accommodate an acutely developing, space-
occupying mass; however, this compensation is lost once a critical volume change has 
occurred, as demonstrated by the inflection point of the pressure–volume relationship (Fig. 
2). Intracranial hypertension and cerebral herniation are “brain codes”—life-threatening 
neurological emergencies indicating that intracranial compliance adaptive mechanisms have 
been overwhelmed.
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Although frequently linked, elevations of intracranial pressure (ICP) and brain herniation 
can occur independently. Intracranial hypertension is defined as a sustained (>5 min) 
elevation of ICP above 20 mmHg [3]. Detection requires invasive monitoring, but certain 
clinical and physiological signs may suggest elevated ICP prior to instrumentation. 
Herniation syndromes result from intracranial compartmental pressure gradients leading to 
parenchymal tissue shifts that compress or displace the brainstem, cranial nerves, or cerebral 
vasculature. Ischemia or infarction from vascular compression may cause edema and further 
deterioration in compliance.
The etiologies of brain codes are classified anatomically as extra-axial, focal, or diffuse 
intraparenchymal processes (Table 1). In the emergent setting of a brain code, resuscitative 
measures are pursued even if the etiological mechanism has not been fully characterized.
Presentation
Clinically, symptoms of increased ICP include headache, nausea, and vomiting, or altered 
mental status with physical signs of hypertension, bradycardia, and irregular respirations or 
apnea (Cushing’s triad), although the concurrence of these three signs is less frequent [4]. 
Common sites for herniation are the cingulum (subfalcine herniation), medial temporal lobe 
(uncal herniation), and inferior cerebellum (tonsillar herniation).
The cardinal signs of transtentorial (uncal) herniation are an acute loss of consciousness 
associated with ipsilateral pupillary dilation and contralateral hemiparesis, resulting, 
respectively, from compression or displacement of ascending arousal pathways, oculomotor 
nerve (III), and corticospinal tract [5, 6]. In a subset of patients, herniation-associated shift 
of the midbrain compresses the contralateral anterior cerebral peduncle (crus cerebri) against 
the tentorium, resulting in hemiparesis that is ipsilateral to the lesion (Kernohan’s false 
localizing sign) [7]. Transtentorial herniation may cause ipsilateral cerebral infarction due to 
occlusion of the posterior cerebral artery.
Neuroimaging
In the emergent setting of a brain code, a cranial computed tomography (CT) scan should be 
obtained to identify a process that may require surgical intervention. Initial resuscitative 
measures and stabilization, including airway interventions, circulatory and ventilatory 
support, and initial hyperosmolar therapy, must be initiated prior to transport to the 
radiology suite. Cranial CT is preferred over magnetic resonance imaging (MRI) due to 
availability and speed of imaging. In the majority of cases, CT will identify the underlying 
process (see Table 1), although MRI may subsequently be needed for characterization. MRI 
should only be sought if the imminent risk of an additional brain code has been addressed by 
medical and/or surgical intervention.
ICP Monitoring
ICP monitors are invasive and are of several different types, including intraventricular 
catheters as well as intraparenchymal, subdural, and epidural devices. The decision to 
proceed with ICP monitoring is determined by the underlying process and the likelihood of 
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its progression. In traumatic brain injury (TBI), neurosurgical guidelines recommended 
placement of an ICP monitor in patients with severe TBI who are comatose after 
resuscitation [Glasgow Coma Scale (GCS) of 3–8] and have either (1) abnormalities on 
cranial CT scan or (2) meet at least two of the following three criteria: age >40 years; 
systolic blood pressure <90 mmHg; or abnormal posturing [8]. Indications for ICP 
monitoring are less well established in nontraumatic coma. However, a recent international 
multidisciplinary consensus conference recommended that ICP and CPP should be 
monitored in patients at risk for ICP elevation based on clinical and/or imaging features to 
guide medical and surgical interventions [9].
Cerebral perfusion pressure (CPP), used as a surrogate for global cerebral blood flow (CBF), 
is approximated by the equation:
CPP = Mean arterial pressure (MAP) – ICP.
In patients with TBI, available data support maintaining CPP >50–60 mmHg in adults to 
prevent cerebral ischemia [3]. Efforts to augment CPP greater than 60 mmHg may elevate 
the risk of systemic complications, including acute respiratory distress syndrome [10]. CPP 
targets for patients with non-traumatic intracranial hypertension have not been adequately 
studied.
Tier Zero
Brain code resuscitation begins with an assessment of circulation, airway patency, and 
ventilation. The head of the bed should be elevated to >30° and the head kept midline to 
facilitate cerebral venous drainage [11, 12]. Stimuli such as tracheal suctioning, that may 
elevate ICP, should be minimized. If hyperthermia is present, measures should be taken to 
normalize body and brain temperature. Only iso- or hyperosmotic fluids should be used as 
intravenous solutions. If hyponatremia is present, steps should be initiated for correction. 
High-dose corticosteroid therapy is initiated for vasogenic edema resulting from brain 
tumors, abscesses, or non-infectious neuroinflammatory conditions [13, 14]. If the brain has 
not yet been imaged, a non-contrast head CT scan should be performed when the patient can 
be transported safely.
Tier One
For acute elevations in ICP, hyperosmolar therapy with either mannitol or hypertonic saline 
(HTS) has shown equivalent efficacy in lowering of ICP [15–18]. Mannitol is administered 
as 0.5–1 g/kg intravenous (IV) bolus through a peripheral intravenous line and may be 
repeated every 4–6 h if serum osmolality is monitored [19]; no therapeutic benefit is 
appreciable with osmolality >320 mOsm/kg. HTS is available in concentrations from 2 to 
23.4 % and can be administered as a bolus alone or in addition to mannitol. HTS 
concentrations boluses C7.5 % should be given via a central venous catheter; when using 
concentrations lower than this, peripheral lines may be used, but the infusion should be in a 
large vessel, and the IV site should be carefully monitored for infiltration. Since two pre-
hospital trials using 7.5 and 3 % NaCl solutions via peripheral catheters had no negative 
effects, in the brain code setting these treatments should not be withheld simply because 
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central access is yet be available [20, 21]. Bolus 23.4 % NaCl has been associated with ICP 
reduction and reversal of transtentorial herniation [22]. When infusing HTS, target serum 
sodium concentration should be determined and serum sodium level checked every 4–6 h. 
When acute obstructive hydrocephalus is present as determined by neuroimaging, an 
external ventricular drainage (EVD) system should be placed emergently. If an EVD system 
is already in place, drain 5–10 mL of CSF [23] for acute rises in ICP. As a temporizing 
measure, a brief course (<2 h) of hyperventilation to a PaCO2 of 30–35 mmHg may be 
considered, while definitive treatment is provided [24, 25]. If ICP is not controlled, and/or 
clinical signs of herniation do not resolve with Tier One interventions, review 
decompressive surgical options [26, 27]. If surgery is not appropriate or not undertaken, 
move to Tier Two. If ICP is controlled with Tier One interventions, consider repeating the 
head CT scan to rule out new processes.
Head CT
After Tier One or Tier Two (below), if brain imaging has not yet been performed, a head CT 
scan should be performed to determine the cause of herniation or intracranial hypertension, 
for the reasons explained in the neuroimaging section above.
Tier Two
If Tier One interventions have failed to control ICP, Tier Two should be engaged. If 
hyperosmolar therapy with HTS has been administered, serum sodium goals should be 
increased, although sodium levels >160 mmol/L are unlikely to provide additional benefit. 
The target for serum sodium is controversial and it depends on pathophysiological state. If 
the patient is continuing to have increased ICP (and needs to advance to Tier Two), one 
needs to maintain a gradient between brain and serum in order to promote the egress of 
water from the brain. Once the ICP has stabilized, one needs to maintain sodium at the 
current high level until the brain edema process is waning. Sedation should be increased to 
aid in ICP management. Propofol has been shown to reduce CMRO2 and CBF volume and, 
consequently, ICP [28]. It is administered as a bolus of 1–3 mg/kg and may be continued as 
an infusion (titrate to maximum 200 µg/kg/min) in ventilated patients. Propofol, especially 
when given as a bolus dose, is associated with circulatory depression, which should be 
corrected with IV fluids and/or vasopressors to maintain CPP goals. A small subset of 
patients receiving propofol may develop a propofol infusion syndrome characterized by 
metabolic acidosis, cardiac dysfunction, rhabdomyolysis, and hypertriglyceridemia, often 
with a fatal outcome [29, 30]. Propofol infusion syndrome is more likely to develop at doses 
>100 mcg/kg/min administered for >48 h; so if propofol is increased to these extreme ranges 
(200 µg/kg/min), it should only be done temporarily, while other measures are put in place.
If ICP is not responsive to Tier Two interventions, rescue decompressive surgery should be 
considered. If the patient is ineligible for surgery, Tier Three (below) should be engaged.
Decompression
Surgery is considered for brain code patients who have failed medical management. 
Decompressive surgical interventions for the management of brain code include (a) 
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placement of a ventricular drain, (b) evacuation of extra-axial lesion (e.g., epidural 
hematoma), (c) resection of intracerebral lesion (e.g., lobar hemorrhage), (d) removal brain 
parenchyma (e.g., cerebellar mass), and (d) uni- or bilateral craniectomies.
Selected patients with rapid neurological deterioration from focal space-occupying lesions 
may benefit from surgical decompression. This includes patients with brain tumors, brain 
abscesses, and parenchymal hemorrhages, particularly when the hemorrhages are lobar [31] 
or cerebellar [32, 33] in location. Decompressive craniectomy may also be considered in 
patients with diffuse brain swelling associated with TBI [34–37]; stroke with brain edema, 
the process in which hemicraniectomy has been most extensively studied [38, 39]; 
meningoencephalitis; or non-infectious neuroinflammatory conditions (e.g. acute 
demyelinating encephalomyelitis).
Tier Three
Tier Three measures represent the most aggressive level of management and carry the 
highest risk of adverse effects. Rigorous randomized prospective studies are lacking, and 
recommendations are driven by consensus. This tier includes administration of pentobarbital 
(bolus 10 mg/kg over 30 min–2 h, then 5 mg/kg/h × 3 h; maintenance infusion of 1–4 
mg/kg/h) titrated to ICP goal. Some patients may not tolerate pentobarbital at these doses 
because of hypotension and arterial vasopressors may be necessary. The 
electroencephalogram (EEG) should be continuously monitored and pentobarbital titrated 
either to ICP or to EEG burst suppression of 5–20 s. The pentobarbital infusion is continued 
for 24–96 h, while the underlying processes driving ICP are treated [40–42]. Pentobarbital is 
associated with respiratory depression, cardiovascular instability, immune suppression, and 
paralytic ileus; neurological examination is limited to an assessment of pupillary reactivity. 
Pentobarbital plasma clearance may take days after discontinuation of infusion; however, it 
redistributes out of the CNS more rapidly.
Moderate hypothermia (target core temperature 32–34 °C) is associated with a predictable 
reduction in ICP. It may be induced with external cooling devices or with IV infusion of 
cooled fluids [43–48]. Hypothermia may be associated with shivering, cardiac arrhythmias, 
sepsis, and electrolyte disturbances and protocols for induction, maintenance, and 
rewarming should be used to optimally manage these complications.
Hyperventilation to achieve mild to moderate hypocapnia (PaCO2 25–35 mmHg) and 
cerebrovascular constriction may be considered in selected patients who have failed other 
interventions in the acute period. Prolonging hyperventilation for more than 6 h is unlikely 
to be beneficial and may cause or exacerbate ischemic injury [25]. Hence, hyperventilation 
should ideally be accomplished in conjunction with a cerebral oxygenation monitor (e.g. 
jugular venous oximetry and brain tissue oxygen probe), in order to detect cerebral ischemia.
Consider Additional Monitoring
Patients who have had or are at risk for a brain code may benefit from additional 
neuromonitoring, including jugular venous oximetry, brain tissue oxygenation, and cerebral 
microdialysis. Treatment based on ICP and CPP overlooks significant information on the 
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physiologic and metabolic state of the injured brain. Moreover, assumptions regarding CPP 
may not hold if CBF autoregulation is impaired. Complementary neuromonitoring 
techniques should be considered to optimize medical management in selected patients with 
severe brain injury.
Studies using brain tissue oxygen sensors indicate that significant parenchymal hypoxia may 
occur even when ICP and CPP are normal [49, 50]. Cerebral microdialysis measures brain 
interstitial lactate, pyruvate, glucose, and glutamate, indicators of cerebral metabolic activity 
whose levels may be altered independently of ICP and CPP [51]. Dynamic indices of 
cerebral autoregulation express the correlation between a systemic hemodynamic parameter 
(arterial blood pressure or CPP) and an intracranial physiological parameter such as ICP 
(PRx), transcranial Doppler-derived CBF velocity (Mx), or brain tissue PO2 (Orx). High 
degrees of correlation suggest a failure of autoregulation and an increased risk of injury due 
to hypo or hyperperfusion [52, 53].
Revise ICP/MAP Goals
Depending on the specific circumstances and the invasive or noninvasive monitoring that 
are available, the standard goals of MAP and ICP should be re-considered and customized to 
the patient. For example, a patient who is awake, without symptoms, and in whom ICP is in 
excess of 20 mmHg, or a CPP below 50 mmHg, may not require any intervention.
Pre-hospital
Recognition of a brain code in the pre-hospital setting is important because life-saving 
therapies can be initiated prior to arrival in the Emergency Department. Clinical signs of 
herniation may be apparent and include unilateral dilated pupil, loss of consciousness, 
posturing, as well as hypertension and bradycardia. Resuscitation begins with the 
management of circulation, airway patency, and ventilation. If capnography is available 
after intubation, a goal of end-tidal CO2 of 30–35 mmHg should be targeted. The head of the 
bed should be elevated to facilitate cerebral venous drainage; although these patients are 
typically backboarded, it may be possible to place a rolled blanket or towel beneath the 
board during transport to elevate the head. Hyperventilation can be initiated using BVM 
ventilation. Pre-hospital notification is also important so that resources are available upon 
arrival.
Pediatric Considerations
Management for intracranial hypertension in the pediatric population should follow 
analogous tiers of treatment and indications for monitoring as in adults. Importantly, the 
presence of an open fontanel in infants does not preclude the development of intracranial 
hypertension and cerebral herniation [54]. In children with TBI <5 years old, CPP should be 
maintained >40 mmHg, whereas in children 6–17 years of age a target of >50 mmHg is 
appropriate [55, 56]. Establishment of optimal CPP may require advanced neuromonitoring 
(i.e., brain tissue oxygen tension) due to the lack of well-defined age-dependent CPP 
thresholds and the risk of abnormal cerebrovascular autoregulation [57].
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Hyperosmolar therapy with either mannitol or 3 % HTS may be administered for ICP 
elevations >20 mmHg or for suspected herniation. Mannitol bolus dose is 0.5–1 g/kg. 
Mannitol can be administered every 4 h as needed for ICP >20 mmHg as long as the 
osmolar gap is less than 20 mOsm. A Foley catheter should be placed in children receiving 
mannitol to prevent bladder overdistention due to mannitol-induced diuresis. Such diuresis 
should be anticipated and additional boluses of normal saline provided to prevent 
hypotension.
Hypertonic 3 % saline may be given as a bolus dose of 5–10 mL/kg for acute elevations in 
ICP or signs of brain herniation. HTS may then be administered as a continuous infusion at 
0.5–1.5 mL/kg/h [55]. The expected serum sodium rise is 1 mEq/L for every 1 mL/kg bolus 
dose given and 1 mEq/L/h for every 1 mL/kg/h continuous infusion. Levels of serum sodium 
>160–165 mEq/L are unlikely to provide additional benefit in reducing intracranial 
hypertension. Compared to mannitol, HTS has the added benefit of improved hemodynamic 
stability, an important consideration given the deleterious effect of hypotension in patients 
with acute brain injury.
Brain herniation is potentially reversible with appropriate and timely therapy. Reversal of 
transtentorial herniation has been observed in 50–75 % of adult patients with either TBI [58] 
or with supratentorial mass lesions [59]. Long-term outcomes after successful treatment for 
herniation may be more favorable in children than in adults [58].
A special category of children at risk for increased ICP and brain herniation are children 
with diabetic ketoacidosis (DKA). Approximately 0.5–1 % of children with DKA will have 
severe cerebral edema, which carries a mortality rate of 20–25 % [60, 61]. Factors thought 
to be associated with increased risk of neurologic complications in pediatric DKA are young 
age, duration and severity of symptoms, low pCO2, overly aggressive fluid resuscitation, 
administration of hypotonic fluids, administration of sodium bicarbonate, and decreases in 
serum glucose >100 mg/dL/h [61, 62]. Hence, initial resuscitation should be administered 
with caution. Boluses of sodium bicarbonate must be avoided. Mental status should be 
checked at least hourly. Children with DKA will often become somnolent with initiation of 
treatment, possibly due to subtler cerebral edema, but they should remain arousable with 
stimulation. Children who are unarousable, those with papilledema and those with warning 
signs of cerebral herniation (Cushing’s triad) should receive hyperosmolar therapy and be 
hyperventilated to prevent further deterioration. HTS may be preferred to mannitol, since in 
DKA osmolality is already high due to elevated glucose concentrations and mannitol-
induced diuresis may aggravate dehydration.
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Intracranial compliance is biphasic
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Table 1
Etiologies of brain code
Extra-axial processes
  Epidural hemorrhage
  Subdural hemorrhage
  Subdural empyema
  Extra-axial brain tumor
  Pneumocephalus
Focal brain processes
  Brain tumor (primary, metastatic)
  Ischemic stroke
  Primary intracerebral hemorrhage
  Brain abscess
  Traumatic brain injury
  Hydrocephalus
Diffuse brain processes
  Traumatic brain injury
  Aneurysmal subarachnoid hemorrhage
  Infectious meningitides and encephalitides
  Non-infectious neuroinflammatory disorders
  Hepatic encephalopathy
  Toxic-metabolic encephalopathies
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